# High expression of ABL2 promotes gastric cancer cells migration, invasion and proliferation via the TGF-β and YAP signaling pathways

**Authors:** Yun Liu, Tao Jin, Ruiyun Chen, Renjie Miao, Yong Zhou, Shihe Shao

PMC · DOI: 10.7150/jca.99307 · Journal of Cancer · 2024-09-09

## TL;DR

High ABL2 levels in gastric cancer cells boost cancer growth and spread by activating specific signaling pathways.

## Contribution

This study reveals ABL2's role in gastric cancer progression via TGF-β and YAP pathways.

## Key findings

- High ABL2 expression correlates with advanced gastric cancer stages and promotes cell proliferation and metastasis.
- ABL2 increases MMP2, MMP9, and PCNA while decreasing TIMP1 and TIMP2 in gastric cancer cells.
- GA-017 counteracts the effects of ABL2 knockdown, suggesting a regulatory interaction with YAP.

## Abstract

Background: The Abelson-Related Gene (ABL2) is expressed in various malignancies. However, its role in gastric cancer (GC) regarding tumor proliferation, metastasis, and invasion remains unclear.

Methods: ABL2 expression in clinical specimens was assessed using quantitative real-time fluorescence PCR (qRT-PCR). Western blotting and immunofluorescence assay determined protein levels. Additionally, Transwell migration and invasion, cell counting kit-8 (CCK-8) and colony-formation assays analyzed the effect of ABL2 on GC cells. Protein levels related to GC cells were assessed through Western blotting. The effects of si-ABL2 combined with GA-017 that activated YAP on cell migration, invasion and proliferation were investigated.

Results: ABL2 expression was upregulated in human GC tissues compared to paracancer tissues, and it was positively related to tumor node metastasis classification (TNM) stage. Furthermore, high ABL2 levels promoted the proliferation, metastasis, and invasion capacity in GC cells. Elevated ABL2 expression enhanced the expression of MMP2, MMP9, and PCNA while decreasing TIMP1 and TIMP2 expression. It also increased the p-SMAD2/3 expression and YAP expression, decreased the expression of p-YAP in GC cells. Furthermore, GA-017 increased ABL2 expression in MGC-803 cells and counteracted the effects of si-ABL2 on cell migration, invasion and proliferation.

Conclusion: These findings indicated that heightened ABL2 expression could activate TGF-β/SMAD2/3 and YAP signaling pathway, promoting epithelial mesenchymal transformation (EMT), and enhancing multiplication, metastasis, and invasion in GC cells.

## Linked entities

- **Genes:** ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) [NCBI Gene 27], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111], TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076], TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413]
- **Chemicals:** GA-017 (PubChem CID 147467531)
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) [NCBI Gene 27] {aka ABLL, ARG}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}
- **Diseases:** metastasis (MESH:D009362), GC (MESH:D013274), malignancies (MESH:D009369), tumor node metastasis (MESH:D008207)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MGC-803 — Homo sapiens (Human), Hybrid cell line (CVCL_5334)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11414612/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11414612/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC11414612/full.md

---
Source: https://tomesphere.com/paper/PMC11414612